RWJBarnabas Health Comments on J&J Vaccine

  • The FDA and CDC have issued national guidance recommending a pause in the administration of the Johnson & Johnson vaccine after six of the 6.8 million people who have received the vaccine experienced rare and severe blood clots.
  • As such, RWJBarnabas Health has immediately halted the use of the Johnson & Johnson vaccine per this guidance.
  • Tomorrow, the federal Advisory Committee on Immunization Practices will meet to further discuss these reported cases of blood clots and determine the best and safest course to follow. We expect additional federal guidance will follow and will share any new information as soon as it is available.
  • Vaccination will continue at our sites using only the Moderna and Pfizer vaccines. Ninety-nine percent of vaccine we have administered has been Moderna and Pfizer. These vaccines are not a part of this safety review.
  • According to the CDC, FDA and NJDOH, individuals who have received the Johnson & Johnson vaccine, and experience abdominal pain, leg pain, shortness of breath, severe headache or other unusual symptoms within three weeks after vaccination should contact their healthcare provider.
  • We know those who have been vaccinated with the J&J vaccine have a number of questions. We will continue to keep you updated as soon as additional information is available.